Abstract: Compounds that inhibit KRas G12D. In particular, compounds that inhibit the activity of KRas G12D, pharmaceutical compositions comprising the compounds and methods of use therefor, and in particular, methods of treating cancer. The compounds have a general structure represented by Formula (I): or a pharmaceutically acceptable salt thereof.

Abstract: One embodiment of case (10) is a thin flexible presentation panel (18a) approximately the size of device (17a) having tabs which wrap over and around device (17a) and attach using hook-and-loop fasteners. A second embodiment is a case body comprising interchangeable components including a case utility panel (24) to which other case components are attached. A retaining strap (26a and 26b) joining means which wraps around device (17b) and may be held stationary with the aid of repeatable instances of repositionable sticker (27) and is grasped, drawn, and stabilized with the aid of clasps (34a, 34b, 34c, and 34d) which are attached to panel (24). Device utility panels (32a and 32b) are attached to panel (24) for containment of articles. Compartment utility panels (30a and 30b) retain compartment enclosures (28a and 28b) which cover any articles contained by panels (32a and 32b). A USB hub (22) for directing power and communicative connectivity is attached to panel (24) and connected to device (17b).